A Dose-Escalation Study of RO5083945 in Patients With Metastatic and/or Locally Advanced Malignant Epidermal Growth Factor Receptor (EGFR)+ Solid Tumors.
Clinical trial NCT00721266 · COMPLETED
Trial details
- NCT number
- NCT00721266
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2011-06-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.